Supply chain issues are lingering but ResMed boss Mick Farrell says the sleep treatment maker can secure long-term market share after a competitor’s major recall.
Brisbane Times – Business
Business
More in:Business
Business
ASX set to rise as Wall Street moves higher; $A slips
US stocks are gaining ground and financial markets worldwide are holding relatively steady as the ...
Business
In one awful decision, Albanese has revealed his do-nothing plan
If you want to govern effectively, you have to be prepared to stand up to ...
Business
‘Highly inefficient’: How AustralianSuper’s death claims backlog ballooned from 700 to 4800
The corporate watchdog has laid out how the fund’s handling of death benefit claims led ...